Carbamazepine-induced B-cell aplasia: Overlooked and overtreated

Ann Allergy Asthma Immunol. 2020 Jan;124(1):89-91. doi: 10.1016/j.anai.2019.10.019. Epub 2019 Nov 4.

Authors

Jane C Y Wong¹, Philip H Li²

Affiliations

¹ Division of Rheumatology & Clinical Immunology, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong. Electronic address: [email protected].
² Division of Rheumatology & Clinical Immunology, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong.

PMID: 31698095
DOI: 10.1016/j.anai.2019.10.019

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Agammaglobulinemia / chemically induced*
B-Lymphocytes / cytology*
Carbamazepine / adverse effects*
Carbamazepine / therapeutic use
Drug Hypersensitivity / pathology*
Female
Humans
Immunoglobulin A / blood
Immunoglobulin G / blood
Immunoglobulin M / blood
Lymphocyte Count
Severe Combined Immunodeficiency / drug therapy
Sodium Channel Blockers / adverse effects*
Sodium Channel Blockers / therapeutic use

Substances

Immunoglobulin A
Immunoglobulin G
Immunoglobulin M
Sodium Channel Blockers
Carbamazepine